Laser ablation can offer an alternative when seizure-producing tissue is close to brain regions responsible for movement, sensation or speech. The procedure is minimally invasive, but it is not performed without entering the skull: clinicians guide a narrow probe through a small opening and use heat to treat the targeted tissue. In Charli Hilz's case, that distinction mattered because the suspected seizure source was near her sensory cortex, according to UT News.
A treatment decision shaped by location
Charli was two when her drug-resistant epilepsy intensified to as many as 20 seizures a day. Her family told UT News that medications, dietary changes and steroids had not controlled the seizures, while her walking, speech and use of her left hand worsened. The family traveled from Dallas to Dell Children's Medical Center in Austin for another evaluation.
At Dell Children's, doctors used advanced imaging and stereo-EEG monitoring, which places electrodes in and around suspected seizure regions, to identify the abnormal electrical activity. The evaluation pointed to a small area of atypical cells near functional tissue. According to the UT News report, removing that area through conventional open surgery could have damaged nearby brain functions, so clinicians instead used a needle-sized probe and laser energy to disable the seizure-driving cells.
Charli is now six and has remained seizure-free, according to UT News. The report says her overnight epileptic activity has largely disappeared, her medication burden has decreased and some previously impaired abilities have returned. The account does not establish how her progress will hold over the longer term or whether further treatment will be needed.
What the Austin center contributes
The case was managed through Dell Children's Comprehensive Pediatric Epilepsy Center. The National Association of Epilepsy Centers lists the program as a Level 4 Pediatric Epilepsy Center and identifies Dave Clarke as its medical director. Clarke, who also holds faculty appointments at Dell Medical School, oversaw Charli's evaluation, according to UT News.
The center's role in this case was not simply to deliver a procedure. The workup first sought to determine whether the seizures began in a localized area, how rapidly they spread and whether treating that area could be done without unacceptable loss of function. That sequence is important in pediatric epilepsy: a favorable result depends on both locating the seizure source and determining whether the surrounding brain can be protected.
Charli's experience therefore illustrates both the potential and the limits of laser treatment. It can avoid a larger craniotomy and reach tissue that may be difficult to remove safely, but it still requires invasive monitoring, precise targeting and a specialized epilepsy team. Her seizure-free result is a report about one child, not proof that the approach will work for every child with drug-resistant epilepsy.
